Targeting PDGF Signaling in Carcinoma-Associated Fibroblasts Controls Cervical Cancer in Mouse Model

1. NgomaT

2006

World Health Organization cancer priorities in developing countries.

Ann Oncol

17

Suppl 8

9

14

2. WaggonerSE

2003

Cervical cancer.

Lancet

361

2217

2225

3. PietrasKPahlerJBergersGHanahanD

2008

Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.

PLoS Med

5

e19

doi:10.1371/journal.pmed.0050019

4. BergersGSongSMeyer-MorseNBergslandEHanahanD

2003

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.

J Clin Invest

111

1287

1295

5. KimSJUeharaHYaziciSBusbyJENakamuraT

2006

Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer.

J Natl Cancer Inst

98

783

793

6. SenninoBFalconBLMcCauleyDLeTMcCauleyT

2007

Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102.

Cancer Res

67

7358

7367

7. SongSEwaldAJStallcupWWerbZBergersG

2005

PDGFRß+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival.

Nature Cell Biol

7

870

879

8. LemonickMDParkA

2001 May 28

New hope for cancer. Time Magazine.

Available: http://www.time.com/time/magazine/article/0,9171,999978,00.html. Accessed 20 December 2007

9. DemetriGDvon MehrenMBlankeCDVan den AbbeeleADEisenbergB

2002

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

N Engl J Med

347

472

480

10. HaberlerCGelpiEMarosiCRösslerKBirnerP

2006

Immunohistochemical analysis of platelet-derived growth factor receptor-a, -b, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy.

J Neurooncol

76

105

109

11. BatchelorTTSorensenAGdi TomasoEZhangWDudaDG

2007

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

Cancer Cell

11

83

95

12. HagendoornJPaderaTPYockTINielsenGPdi TomasoE

2006

Platelet-derived growth factor receptor-beta in Gorham's disease.

Nat Clin Pract Oncol

3

693

697

13. CohenMHWilliamsGJohnsonJRDuanJGobburuJ

2002

Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.

Clin Cancer Res

8

935

942

14. JainRK

2005

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Science

307

58

62

15. XianXHakanssonJStahlbergALindblomPBetsholtzC

2006

Pericytes limit tumor cell metastasis.

J Clin Invest

116

642

651